Literature DB >> 12402171

High incidence of JC viruria in JC-seropositive older individuals.

Han Chang1, Meilin Wang, Rong-Tai Tsai, Hui-Sheng Lin, Jin-Shue Huan, Wen-Chuang Wang, Deching Chang.   

Abstract

The prevalence of the human JC virus (JCV) in the general population at various ages was investigated. Polymerase chain reaction was employed to detect viral DNA in the urine. The results showed that the incidence of JC viruria was low in the young population, but it was high in the elderly. Hemagglutination inhibition assay was performed for JCV seroprevalence study. The results showed that the seropositive rate of JCV was lower in children than that in adults. The ratio of viruria to seropositive for JCV increased with age and reached 79.7% for those older than 70 years. The results indicated that aging immunity may correlate with JCV reactivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402171     DOI: 10.1080/13550280260422758

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  48 in total

1.  JC virus genotypes in a Taiwan aboriginal tribe (Bunun): implications for its population history.

Authors:  D Chang; C Sugimoto; M Wang; R T Tsai; Y Yogo
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

Review 2.  New aspects in the pathogenesis of polyomavirus-induced disease.

Authors:  K Dörries
Journal:  Adv Virus Res       Date:  1997       Impact factor: 9.937

3.  Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Authors:  R S Hamilton; M Gravell; E O Major
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

Review 5.  Post-transplantation polyomavirus infections.

Authors:  S Boubenider; C Hiesse; S Marchand; A Hafi; F Kriaa; B Charpentier
Journal:  J Nephrol       Date:  1999 Jan-Feb       Impact factor: 3.902

6.  Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants.

Authors:  R R Arthur; K V Shah; S J Baust; G W Santos; R Saral
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

7.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

8.  BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions.

Authors:  A Sundsfjord; T Flaegstad; R Flø; A R Spein; M Pedersen; H Permin; J Julsrud; T Traavik
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

9.  Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients.

Authors:  T Tominaga; Y Yogo; T Kitamura; Y Aso
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

10.  Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.

Authors:  P M Chesters; J Heritage; D J McCance
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  23 in total

Review 1.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Detecting viral genomes in the female urinary microbiome.

Authors:  Andrea Garretto; Krystal Thomas-White; Alan J Wolfe; Catherine Putonti
Journal:  J Gen Virol       Date:  2018-06-11       Impact factor: 3.891

3.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

Review 4.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Authors:  Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-09

6.  Detection of human JCPyV and BKPyV in diffuse large B-cell lymphoma of the GI tract.

Authors:  C E Tseng; C M Yeh; C Y Fang; J Shay; P L Chen; M C Lin; D Chang; M Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-21       Impact factor: 3.267

7.  JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study.

Authors:  Britta Höcker; Julia Tabatabai; Lukas Schneble; Jun Oh; Florian Thiel; Lars Pape; Krisztina Rusai; Rezan Topaloglu; Birgitta Kranz; Günter Klaus; Nikoleta Printza; Onder Yavascan; Alexander Fichtner; Kai Krupka; Thomas Bruckner; Rüdiger Waldherr; Michael Pawlita; Paul Schnitzler; Hans H Hirsch; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2018-07-30       Impact factor: 3.714

8.  JC virus infection is acquired very early in life: evidence from a longitudinal serological study.

Authors:  Francesca Elia; Sonia Villani; Federico Ambrogi; Lucia Signorini; Simone Dallari; Sandro Binda; Valeria Primache; Laura Pellegrinelli; Pasquale Ferrante; Serena Delbue
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

9.  Adipocyte Plasma Membrane Protein (APMAP) promotes JC Virus (JCPyV) infection in human glial cells.

Authors:  Sheila A Haley; Bethany A O'Hara; Walter J Atwood
Journal:  Virology       Date:  2020-06-07       Impact factor: 3.616

10.  Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.

Authors:  Dana E Rollison; Kathy J Helzlsouer; Ji-Hyun Lee; William Fulp; Sandra Clipp; Judy A Hoffman-Bolton; Anna R Giuliano; Elizabeth A Platz; Raphael P Viscidi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.